C231H412N20 — CID 167573783
bis(4-cyclohexyl-1-propan-2-ylpiperidine);4-cyclopentyl-1-propan-2-ylpiperidine;3-(2,4-dimethylphenyl)-1-propan-2-ylazetidine;4,4-dimethyl-1-propan-2-ylpiperidine;3-(3-methylphenyl)-1-propan-2-ylpiperidine;3-(4-methylphenyl)-1-propan-2-ylpiperidine;5-methyl-2-propan-2-yl-1,3-dihydroisoindole;2-methyl-1-propan-2-ylpiperidine;3-methyl-1-propan-2-ylpiperidine;pentakis(4-methyl-1-propan-2-ylpiperidine);3-phenyl-1-propan-2-ylazetidine;3-phenyl-1-propan-2-ylpiperidine;4-phenyl-1-propan-2-ylpiperidine;3-phenyl-1-propan-2-ylpyrrolidine;1-propan-2-ylpiperidine (PubChem CID 167573783) has the molecular formula C231H412N20 and a molecular weight of 3469.98 g/mol. Its IUPAC name is bis(4-cyclohexyl-1-propan-2-ylpiperidine);4-cyclopentyl-1-propan-2-ylpiperidine;3-(2,4-dimethylphenyl)-1-propan-2-ylazetidine;4,4-dimethyl-1-propan-2-ylpiperidine;3-(3-methylphenyl)-1-propan-2-ylpiperidine;3-(4-methylphenyl)-1-propan-2-ylpiperidine;5-methyl-2-propan-2-yl-1,3-dihydroisoindole;2-methyl-1-propan-2-ylpiperidine;3-methyl-1-propan-2-ylpiperidine;pentakis(4-methyl-1-propan-2-ylpiperidine);3-phenyl-1-propan-2-ylazetidine;3-phenyl-1-propan-2-ylpiperidine;4-phenyl-1-propan-2-ylpiperidine;3-phenyl-1-propan-2-ylpyrrolidine;1-propan-2-ylpiperidine.
| Compound Name | bis(4-cyclohexyl-1-propan-2-ylpiperidine);4-cyclopentyl-1-propan-2-ylpiperidine;3-(2,4-dimethylphenyl)-1-propan-2-ylazetidine;4,4-dimethyl-1-propan-2-ylpiperidine;3-(3-methylphenyl)-1-propan-2-ylpiperidine;3-(4-methylphenyl)-1-propan-2-ylpiperidine;5-methyl-2-propan-2-yl-1,3-dihydroisoindole;2-methyl-1-propan-2-ylpiperidine;3-methyl-1-propan-2-ylpiperidine;pentakis(4-methyl-1-propan-2-ylpiperidine);3-phenyl-1-propan-2-ylazetidine;3-phenyl-1-propan-2-ylpiperidine;4-phenyl-1-propan-2-ylpiperidine;3-phenyl-1-propan-2-ylpyrrolidine;1-propan-2-ylpiperidine |
|---|---|
| PubChem CID | 167573783 |
| Molecular Formula | C231H412N20 |
| Molecular Weight | 3469.98 g/mol |
| Exact Mass | 3467.29 |
| IUPAC Name | bis(4-cyclohexyl-1-propan-2-ylpiperidine);4-cyclopentyl-1-propan-2-ylpiperidine;3-(2,4-dimethylphenyl)-1-propan-2-ylazetidine;4,4-dimethyl-1-propan-2-ylpiperidine;3-(3-methylphenyl)-1-propan-2-ylpiperidine;3-(4-methylphenyl)-1-propan-2-ylpiperidine;5-methyl-2-propan-2-yl-1,3-dihydroisoindole;2-methyl-1-propan-2-ylpiperidine;3-methyl-1-propan-2-ylpiperidine;pentakis(4-methyl-1-propan-2-ylpiperidine);3-phenyl-1-propan-2-ylazetidine;3-phenyl-1-propan-2-ylpiperidine;4-phenyl-1-propan-2-ylpiperidine;3-phenyl-1-propan-2-ylpyrrolidine;1-propan-2-ylpiperidine |
| SMILES | CC(C)N1CC(c2ccccc2)C1.CC(C)N1CCC(C)(C)CC1.CC(C)N1CCC(C2CCCC2)CC1.CC(C)N1CCC(C2CCCCC2)CC1.CC(C)N1CCC(C2CCCCC2)CC1.CC(C)N1CCC(c2ccccc2)C1.CC(C)N1CCC(c2ccccc2)CC1.CC(C)N1CCCC(c2ccccc2)C1.CC(C)N1CCCCC1.CC(C)N1CCCCC1C.CC1CCCN(C(C)C)C1.CC1CCN(C(C)C)CC1.CC1CCN(C(C)C)CC1.CC1CCN(C(C)C)CC1.CC1CCN(C(C)C)CC1.CC1CCN(C(C)C)CC1.Cc1ccc(C2CCCN(C(C)C)C2)cc1.Cc1ccc(C2CN(C(C)C)C2)c(C)c1.Cc1ccc2c(c1)CN(C(C)C)C2.Cc1cccc(C2CCCN(C(C)C)C2)c1 |
| InChI | InChI=1S/2C15H23N.2C14H21N.2C14H27N.C14H21N.C13H25N.C13H19N.2C12H17N.C10H21N.7C9H19N.C8H17N/c1-12(2)16-9-5-8-15(11-16)14-7-4-6-13(3)10-14;1-12(2)16-10-4-5-15(11-16)14-8-6-13(3)7-9-14;1-10(2)15-8-13(9-15)14-6-5-11(3)7-12(14)4;1-12(2)15-10-6-9-14(11-15)13-7-4-3-5-8-13;3*1-12(2)15-10-8-14(9-11-15)13-6-4-3-5-7-13;1-11(2)14-9-7-13(8-10-14)12-5-3-4-6-12;1-11(2)14-9-8-13(10-14)12-6-4-3-5-7-12;1-9(2)13-7-11-5-4-10(3)6-12(11)8-13;1-10(2)13-8-12(9-13)11-6-4-3-5-7-11;1-9(2)11-7-5-10(3,4)6-8-11;5*1-8(2)10-6-4-9(3)5-7-10;1-8(2)10-6-4-5-9(3)7-10;1-8(2)10-7-5-4-6-9(10)3;1-8(2)9-6-4-3-5-7-9/h4,6-7,10,12,15H,5,8-9,11H2,1-3H3;6-9,12,15H,4-5,10-11H2,1-3H3;5-7,10,13H,8-9H2,1-4H3;3-5,7-8,12,14H,6,9-11H2,1-2H3;2*12-14H,3-11H2,1-2H3;3-7,12,14H,8-11H2,1-2H3;11-13H,3-10H2,1-2H3;3-7,11,13H,8-10H2,1-2H3;4-6,9H,7-8H2,1-3H3;3-7,10,12H,8-9H2,1-2H3;9H,5-8H2,1-4H3;7*8-9H,4-7H2,1-3H3;8H,3-7H2,1-2H3 |
| InChIKey | GGJLDNJOBUOWLR-UHFFFAOYSA-N |
| XLogP | 55.02 |
| TPSA | 64.80 Ų |
| H-Bond Donors | |
| H-Bond Acceptors | 20 |
| Rotatable Bonds | 30 |
| Heavy Atoms | 251 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 3469.98 |
| LogP ≤ 5 | 55.02 |
| H-Bond Donors ≤ 5 | 0 |
| H-Bond Acceptors ≤ 10 | 20 |